旧金山——根据向美国证券交易委员会提交的监管文件，Hims & Hers Health, Inc. (NYSE:HIMS)的首席商务官Michael Chi最近出售了公司股票，价值约16.5万美元。 根据10b5-1交易计划执行的这笔交易涉及以每股22.00美元的价格出售7,500股A类普通股。此次出售后，Chi的直接持股减少至183,980股。

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article, we ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

旧金山——根据最近的SEC文件，Hims & Hers Health Inc. (NYSE:HIMS)的首席会计官Becklund Irene于2024年11月18日执行了一系列股票交易。 Irene行权获得472股A类普通股，每股价格为9.41美元。随后，她以每股19.42美元的价格出售了相同数量的股票，总销售价值为9,166美元。这些交易是根据2023年9月11日采用的预先安排的交易计划进行的 ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Hims & Hers Health ( HIMS, Financials) shares slumped 24.5% on Thursday as Amazon ( AMZN, Financials) expanded into hair loss ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...